Attention: You are using an outdated browser, device or you do not have the latest version of JavaScript downloaded and so this website may not work as expected. Please download the latest software or switch device to avoid further issues.

News > Research buzz > New proteomic technology accelerates COVID-19 biomarker and exploratory drug discovery

New proteomic technology accelerates COVID-19 biomarker and exploratory drug discovery

Researchers at the Crick have developed a new mass spectrometric acquisition technology, Scanning SWATH, that measures the human proteome faster and at a lower cost than its predecessors.
31 Mar 2021
United Kingdom | Germany
Research buzz

To view this News Article please log in or create a profile

Similar stories

The researchers liken the dual role of CDKN2A to the ancient Roman god of transitions Janus,

Researchers from the Crick and Barts have shown that a genetic fault long believed to drive the development of oesophageal cancer may in fact play a protective role early in the di… More...

Researchers at the Crick, MRC Harwell Institute and UCL Queen Square Institute of Neurology have identified the genetic … More...

Colleagues have generated human stem cell models which, for the first time, contain notochord – a tissue in the developi… More...

Waves of human migration across Europe during the first millennium AD have been revealed using a more precise method of … More...

Have your say

 
image

Contact us

The Francis Crick Institute
1 Midland Road
London
NW1 1AT

connect@crick.ac.uk